{
    "2020-08-10": [
        [
            {
                "time": "",
                "original_text": "天坛生物现2笔大宗交易 ，共成交750.15万元",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "大宗交易",
                        "成交金额"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：中报窗口期继续看好业绩高增长板块 ，持续推荐有实力能兑现的疫苗公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报",
                        "业绩高增长",
                        "疫苗公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161)：受疫情影响终端需求未完全恢复 ，收入同比略有下降 ，长期成长逻辑不改",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "疫情",
                        "终端需求",
                        "收入下降",
                        "长期成长逻辑"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}